A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
The Pros and Cons of Investing in REITs
About 45% of American households invest in REITs. Jeremy Pagan, research analyst with Morningstar Inc., joined Cheddar News to explain the pros and cons of investing in REITs.
The Fate of TikTok in the U.S.
A Republican-led House panel voted to advance a bill that would give President Joe Biden the power to ban TikTok. Chris Pierson, the founder and CEO of BlackCloak, joined Cheddar News to discuss how the process could affect other businesses.
Understanding Same Day Options
Arianne Adams, Head of Derivatives and Global Client Services at CBOE, joins Cheddar News to break down what exactly same day options are, how they are traded, the benefits of same day options, and so much more.
Load More